Please sign in to follow a disease.
Can scoping the gut save ICU patients with hidden bleeding?
NCT ID NCT07829978
First seen Sep 21, 2026 · Last updated Sep 21, 2026
Summary
Researchers at Fayoum University Hospitals are studying how urgent upper and lower gastrointestinal endoscopy affects critically ill patients in the intensive care unit. The trial enrolls 60 adults with overt or suspected GI bleeding. Doctors use endoscopy to look for a diagnosis and to perform treatments such as stopping bleeding. The study tracks how often endoscopy finds a relevant problem, how often it leads to a therapeutic procedure, and how these relate to ICU stay, complications, and death.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- upper and lower gastrointestinal endoscopy
- What this could lead to
- If endoscopy proves useful, doctors could identify and treat the source of GI bleeding faster in ICU patients, potentially shortening hospital stays and improving survival.
- What could go wrong
- Critically ill patients are fragile, and moving them for endoscopy carries risks. The trial is small and observational, so it may not show whether endoscopy changes outcomes or just finds bleeding that would have resolved anyway.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2025
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who admitted to the ICU with indication for upper and lower gastrointestinal endoscopy from January 2025 to January 2027 in Fayoum University Hospitals will be included.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Critically ill Patients with overt gastrointestinal bleeding * Critically ill Patients with suspected gastrointestinal bleeding manifestations as: * Acute and unexplained anemia * Sudden unexplained hemodynamic instability * Prolonged Ryle feeding (10 days) * Prolonged intubation (7 days) * Prolonged hospitalization with occult blood in stool * Prolonged administration of anticoagulants (2 weeks) * Prolonged PPI treatment and history of peptic ulcer * Critically ill Patients with other indications as: * Immunocompromised patients with oral candidiasis * Persistent unexplained vomiting * Dysphagia and odynophagia * Intractable or chronic gastro esophageal reflux disease * Chronic unexplained diarrhea * Unexplained Iron deficiency anemia in old age * Suspicion of malignant ulcer (peptic or colonic) * Cancer of unknown origin * Duodenal biopsy * Suspicion of colonic mass Exclusion Criteria: * Patient refusal * Noncompliance * Facial trauma * Patient age less than 18 years old
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Git bleeding are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine Fayoum University
Al Fayyum, Faiyum Governorate, 63521, Egypt